Iress (ASX:IRE): Is This Fintech Stock Is Worth Watching After Its Margin-Driven H1 2026 Result

Sonal Goyal

17 September 2026 07:32 PM AEST

Iress (ASX:IRE): Is This Fintech Stock Is Worth Watching After Its Margin-Driven H1 2026 Result

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Iress Limited (ASX:IRE) reported H1 2026 Statutory NPAT of $32.0 million, up 85.0% on the prior corresponding period, with shares trading at $5.68, up 0.89%, during the Trading session on 17 September 2026.
Continuing Business Cash EBITDA increased 47.1% on a constant currency basis to $61.1 million, with the Cash EBITDA Margin expanding more than 740 basis points to 24.5%.
The company declared a fully franked Interim Dividend of 14.0 cents per share, 27.3% higher than the prior corresponding period.
Iress updated its FY26 guidance, now expecting softer constant currency Revenue growth of 1-2% alongside higher Cash EBITDA growth of 21-26%.

Iress Limited (ASX:IRE) shares traded at $5.68, up 0.89%, during the trading session on 17 September 2026. The financial technology company recently released its results for the half year ended 30 June 2026 (1H26), reporting materially improved Earnings quality and margin expansion, which it attributed to disciplined execution across its continuing business.

1H26 Financial Results

Iress reported Statutory NPAT of $32.0 million for 1H26, up 85.0% on 1H25. The Group's preferred profitability measure, Underlying Profit after tax, increased 18.4% to $38.8 million. For the continuing business, comprising APAC Wealth, GTMD and UK Wealth & Sourcing, revenue increased 2.5% on a constant currency basis to $250.0 million, while Recurring Revenue increased 3.4% to $237.8 million, representing 95% of Group revenue.

Continuing business Cash EBITDA for the half rose materially, 47.1% higher on a constant currency basis to $61.1 million, with the Cash EBITDA margin expanding more than 740 basis points to 24.5%. The company attributed this to higher revenue, the benefits of its business efficiency program, and lower first-half capital expenditure. The business efficiency program remained ahead of plan, delivering $31.5 million of annualised cost savings, with a further $6-9 million expected in the second half of 2026.

The company's Balance Sheet continued to strengthen, with Leverage of 0.5x at 30 June 2026, providing financial flexibility to self-fund disciplined Investment in product evolution while retaining optionality for future capital management initiatives.

Dividend Declaration

Reflecting its strong financial position, the Board declared a fully franked interim dividend of 14.0 cents per share, 27.3% higher than the prior corresponding period.

Strategic Progress

Iress described its execution as having shifted from simplifying the business to investing in product evolution and sustainable growth. The company's Thoughtworks Partnership has been mobilised, with AI being embedded across engineering and product development, including the next evolution of Xplan capabilities such as AI-enabled adviser workflow and productivity tools and a refreshed client portal. CEO and Managing Director Andrew Russell said the company remains confident in delivering its FY26 Cash EBITDA margin exit run-rate target of 25%.

Updated FY26 Guidance

Iress updated its FY26 constant currency guidance, with revenue growth now expected to be 1-2%, reflecting lower non-recurring revenue. Cash EBITDA growth is expected to be 21-26% and Underlying profit after tax growth 15-21%, reflecting the benefits of structural business efficiencies and disciplined cost management. Reflecting a 6-8% appreciation of the Australian dollar against relevant currencies during 2026, reported FY26 revenue is now expected to be in the range of $499-505 million, Cash EBITDA $119-124 million and Underlying profit after tax $82-86 million.

Key Takeaways

Iress reported a substantial improvement in earnings quality for the first half of 2026, with Statutory NPAT and Cash EBITDA both rising sharply as margin expansion outpaced more modest revenue growth in its continuing business. The higher interim dividend, updated FY26 guidance reflecting stronger profitability alongside softer revenue growth, and continued investment through the Thoughtworks partnership point to a company in the midst of transitioning its strategic focus from cost simplification toward product evolution and longer-term growth.

FAQs

Q: What was Iress' H1 2026 Statutory NPAT?

A: Statutory NPAT rose 85.0% to $32.0 million, up from the prior corresponding period.

Q: How much did Iress' Cash EBITDA margin expand in H1 2026?

A: Continuing business Cash EBITDA margin expanded more than 740 basis points to 24.5%, with Cash EBITDA up 47.1% on a constant currency basis to $61.1 million.

Q: What dividend did Iress declare for H1 2026?

A: The company declared a fully franked interim dividend of 14.0 cents per share, 27.3% higher than the prior corresponding period.

Q: Did Iress update its FY26 guidance?

A: Yes, revenue growth guidance was lowered to 1-2% on constant currency, while Cash EBITDA growth guidance was raised to 21-26%.

Q: What is the Thoughtworks partnership?

A: It is a strategic partnership that has been mobilised to accelerate engineering capability, AI adoption, and delivery velocity across Iress' product portfolio, including Xplan.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.